دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 30,000,000 تومان- قیمت ویژه : 8,250,000تومان
دسترسی یکماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 31 ﺭﻭﺯ
قیمت : 3,000,000 تومان- قیمت ویژه : 1,250,000تومان
Focus on mechanisms and management of acute and non-acute ischaemic syndromes
doi : 10.1093/eurheartj/ehaf495
Volume 46, Issue 29, 1 August 2025
Epidemic of cardio-metabolic disorders in south Asia: need for urgent solutions
European Research Council–funded grant: tight junctions and heart regeneration
The ‘10 Commandments’ from the 2025 ESC/EHRA Clinical Consensus Statement on Indications for Conduction System Pacing (CSP)
Cardio-oncology rehabilitation and exercise: evidence, priorities, and research standards from the ICOS-CORE working group
Acute coronary syndromes: mechanisms, challenges, and new opportunities
Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction
Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trial
Staring into the AβYSS: how many pills and for how long after myocardial infarction?
Long-term effect of biodegradable vs. durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial
Statins beat device-related in-stent neo-atherosclerosis: pathophysiology reigns supreme
Exercise electrocardiography stress testing in suspected angina and non-obstructive coronary arteries
Coronary inflammation and cardiovascular risk in breast cancer after radiotherapy
Addressing sample overlap and meta-analysis imbalances in Mendelian randomization: a critical appraisal of protein targets for myocardial infarction
Applying Mendelian randomization to study the relationship between circulating proteins and myocardial infarction
Erythritol and xylitol and cardiovascular disease risk: a growing concern
Weekly Journal Scan: Effects of oral semaglutide on cardiovascular outcomes in patients with type 2 diabetes and high risk profile
